TALARIS THERAPEUTICS
LIVE

Serial Number

88197017

Owner

Regenerex, Inc.

Attorney

Maya L. Tarr

First Use Date

Feb 26, 2020

Filing Date

Nov 16, 2018

Add to watchlist:

No watchlists yet
View on USPTO

TALARIS THERAPEUTICS Trademark

Serial Number: 88197017 • Registration: 6180755

TALARIS THERAPEUTICS is a trademark filed by Regenerex, Inc. on November 16, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Regenerex, Inc.

Louisville, KY 40202

Entity Type: 03

TALARIS THERAPEUTICS, INC.

201 EAST JEFFERSON STREET, SUITE 110B
LOUISVILLE, KY 40202

Entity Type: 03

Trademark Details

Filing Date

November 16, 2018

Registration Date

October 20, 2020

First Use Anywhere

February 26, 2020

First Use in Commerce

February 26, 2020

Published for Opposition

November 12, 2019

Goods & Services

Providing laboratory services to hospitals and transplant centers involving manipulation of allogeneic cells used for cell therapy treatment of organ transplant patients

Biological preparations in the nature of allogeneic cell therapies for use in treating organ transplant patients

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Oct 20, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
Oct 20, 2020 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sep 16, 2020 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 15, 2020 CNPR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 19, 2020 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Aug 18, 2020 SUPC
SOU EXTENSION 2 GRANTED
Aug 18, 2020 EX2G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 18, 2020 AITU
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Aug 12, 2020 ASGN
USE AMENDMENT FILED
Aug 7, 2020 IUAF
SOU EXTENSION 2 FILED
Aug 7, 2020 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 7, 2020 EEXT
TEAS STATEMENT OF USE RECEIVED
Aug 7, 2020 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 8, 2020 EXRA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 7, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 7, 2020 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jul 7, 2020 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 7, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 7, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 7, 2020 COAR
SOU EXTENSION 1 GRANTED
Jul 6, 2020 EX1G
SOU EXTENSION 1 FILED
Jul 6, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 6, 2020 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 7, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 12, 2019 NPUB
PUBLISHED FOR OPPOSITION
Nov 12, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 23, 2019 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 9, 2019 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 8, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 8, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 8, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 8, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 8, 2019 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 27, 2019 GNFN
FINAL REFUSAL E-MAILED
Sep 27, 2019 GNFR
FINAL REFUSAL WRITTEN
Sep 27, 2019 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 4, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 4, 2019 CRFA
ASSIGNED TO LIE
Sep 2, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 27, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 28, 2019 GNRN
NON-FINAL ACTION E-MAILED
Feb 28, 2019 GNRT
NON-FINAL ACTION WRITTEN
Feb 28, 2019 CNRT
ASSIGNED TO EXAMINER
Feb 20, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 4, 2018 NWOS
NEW APPLICATION ENTERED
Nov 20, 2018 NWAP